Key result
In a mouse model of pulmonary embolism, administration of 100 μm thrombi resulted in dose-dependent survival and significantly increased IL-6 mRNA expression in the embolized lungs.
Why the study?
Previous models of pulmonary embolism showed large variability in ischemia, complicating assessment of pathophysiological lung responses after embolization.
A reproducible murine model of pulmonary embolism using 100 μm thrombi demonstrates acute local inflammatory responses, including increased IL-6 expression in macrophages.
Answers are grounded in this paper and cite their sources.
This murine PE model enables targeted inflammation studies; leaves open translation to human thromboinflammation and therapies.
Background Since previously established models of pulmonary embolism showed a large variability in the degree of ischemia, it is difficult to assess the pathophysiological response in the lung after embolization. Here, we established a model of pulmonary embolism by certain amount of relatively small thrombi, in which the degree of ischemia was reproducible. Methods Thrombi with a maximum diameter of 100 μm or 500 μm were administered intravenously under anesthesia, and the survival ratio at 4 hours was evaluated. The location of thrombi in the lung was visualized by administration of fluorescent-labeled thrombus, and the hemodynamics of the lung after administration of thrombi was evaluated. CT angiography was also performed to evaluate the ratio of the embolized vessels. In addition, cytokine mRNAs was quantified 4 hours in embolized lung. Immunohistochemical analysis for interleukin (IL)-6 and CD68 as a marker of macrophages were also performed. Results It was found that mice with 100 μm clots, but not with 500 μm clots, showed a dose-dependence of survival between 2.3 μL/g and 3.0 μL/g at 4 hours from embolization induction. In mice treated with 2.5 μL/g of 100 μm thrombus, thrombi were located in the peripheral region of the lung, which was consistent with the disruption of blood circulation the peripheral region. In addition, about 60% of the vessels with a diameter of less than 100 μm were occluded in these mice. In the lungs after 4 hours of embolization, IL-6 mRNA and tumor necrosis factor (TNF)-α mRNA were significantly higher and lower than control lungs. IL-6 was expressed in CD68-positive macrophages in both embolized and control lungs after 4 hours of embolization, and the number of each positive cells were comparable in both embolized and control lungs. Conclusions These results show that the pulmonary embolization model induced by a certain amount of small thrombus is useful for evaluating the pathological responses in the embolized lung. Furthermore, it was found that IL-6 expression was increased in macrophages in the embolized lung, indicating that inflammatory responses may contribute to the pathogenesis of pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Okabe et al. (2022) studied Pulmonary embolism (n=73). 100 μm thrombi vs. Control lungs or 500 μm thrombi was evaluated on Survival ratio at 4 hours. In a mouse model of pulmonary embolism, administration of 100 μm thrombi resulted in dose-dependent survival and significantly increased IL-6 mRNA expression in the embolized lungs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: